The next petition for consideration is PE1690, by Emma Shorter, on behalf of #MEAction Scotland, on the treatment of people with myalgic encephalomyelitis. Members will recall that we took evidence on the petition from the petitioner and agreed to write to a range of stakeholders, including the Scottish Government and health boards.
The clerk’s note provides a summary of the submissions that have been received from health boards, which appear to justify the concerns that the petitioner expressed in her petition and in her oral evidence about an inconsistency of approach or awareness across health boards. We have also received submissions from individuals who have outlined their experiences, particularly of cognitive behavioural therapy and graded exercise therapy. Their views appear to be supported by stakeholders including science for ME and Action for ME.
In response, NHS Education for Scotland has referred to a learning matrix that it has produced, which says that cognitive behavioural therapy
“has the clearest evidence of benefit”.
The Scottish Government acknowledged that CBT can result in some people feeling worse but noted that studies have found that it has benefits for others.
On our desks, we have copies of submissions that were not included in our meeting pack, as they are in the process of being published. Invest in ME Research has set out why it believes that greater funding is required for biomedical research into ME. It considers that the delivery of training and education needs to be overseen by experienced clinicians and suggests that claims about the efficacy of CBT are “misleading”.
Stuart Brown seeks clarification on the Scottish Government submission, particularly with regard to the “actual government spend” within the £90,000 of funding that it recently announced for research. He raises concerns about the Scottish Government’s reference to the £2.5 million that it has invested in specialist nursing and care and argues that that money was not spent on patients with ME and
“nor did the Government particularly intend it to be”.
Do members have any comments or suggestions for action? I am struck by the number of responses and by the powerful arguments that are being put forward. I also found the evidence from Professor Jonathan Edwards interesting, although I do not pretend to understand all the issues. We are not clinicians, so I am always anxious about intervening in clinical matters where people have expertise, but his explanation of why bias is built in around behavioural issues was very interesting. The pattern of experience of those who made submissions is also significant.
